Skip to main content
SpringerLink
Log in

Immunotherapy

  • Chapter
Combination Therapy in Urological Malignancy

Part of the book series: Clinical Practice in Urology ((PRACTICE UROLOG))

  • 49 Accesses

Abstract

The manipulation of the immune system as a means of cancer therapy has held the interest of researchers and clinicians for many years. Rapidly developing knowledge in molecular biology, recombinant DNA technology and hybridoma technology has allowed a more sophisticated approach to the understanding of the immune system and its role in tumour immunology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Anderson TM, Ibayashi Y, Holmes EC et al. (1987) Modification of natural killer activity of lymphocytes infiltrating human lung cancers. Cancer Immunol Immunother 25: 65 – 68

    Article  PubMed  CAS  Google Scholar 

  • Anderson TM, Iboyashi Y, Tokuda Y et al. (1988) Effects of systemic interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphocytes. Cancer Res 48: 1180 – 1187

    PubMed  CAS  Google Scholar 

  • Balkwell FR, Ward BF, Moodie E, Fiers W (1987) Therapeutic potential of tumor necrosis factor-a and g-interferon in experimental human ovarian cancer. Cancer Res 47: 4755 – 4758

    Google Scholar 

  • Bander NH (1987) Monoclonal antibodies in urologic oncology. Cancer [suppl] 60: 658 – 667

    CAS  Google Scholar 

  • Bugelski PJ, Corwin SP, North SM, Kirsh RL, Nicolson GL, Poste G (1987) Macrophage content of spontaneous metastases at different stages of growth. Cancer Res 47: 4141 – 4145

    PubMed  CAS  Google Scholar 

  • Cummings KB, Schmid SM, Bryan GT, Border EC (1986) Antiproliferative activity of recombinant interferons alpha and beta for human renal carcinoma cells: Supra-additive activity with elevated temperature or vinblastine. World J Urol 3: 230–233

    Article  Google Scholar 

  • Droller MJ (1987) Biologic response modifiers in genitourinary neoplasia. Cancer 60 [suppl]: 635 – 644

    Article  PubMed  CAS  Google Scholar 

  • Fahey JR, Hines DL (1987) Progressive growth of immunogenic tumors: Relationship between susceptibility of ascites p815 tumor cells to T-cell-mediated lysis and immune destruction in vivo. Cancer Res 47: 4759 – 4765

    PubMed  CAS  Google Scholar 

  • Goldstein D, Laszlo J (1986) Interferon therapy in cancer: from imaginon to interferon. Cancer Res 46: 4315 – 4329

    PubMed  CAS  Google Scholar 

  • Grups JW, Schmitz-Drager BJ, Ebert T, Ackermann R (1986) Biologic potentials of interferon’s relevance in the systemic treatment of superficial bladder carcinoma. World J Urol 3: 224 – 229

    Article  Google Scholar 

  • Hersey P, Bindon C, Edwards A, Murray E, Phillips G, McCarthy WH (1981) Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2. Int J Cancer 28: 695 – 703

    Article  PubMed  CAS  Google Scholar 

  • Kedar E, Ikejiri BL, Timonen T, Bonnard GD, Reid J, Navvarro NJ, Sredni B, Heberman RB (1983) Antitumor reactivity in vitro and in vivo of lymphocytes from normal donors and cancer’ patients propagated in culture with T-cell growth factor (TCGF). Eur J Cancer Clin Oncol 19: 757–773

    Article  PubMed  CAS  Google Scholar 

  • Kohler G (1986) Derivation and diversification of monoclonal antibodies. Science 233: 1281 – 1286

    Article  PubMed  CAS  Google Scholar 

  • Kradin RL, Boyle LA, Preffer FI et al. (1987) Tumor-derived, interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol Immunother 24: 76 – 85

    Article  PubMed  CAS  Google Scholar 

  • Krown SE (1987) Interferon treatment of renal cell carcinoma. Cancer [supplement] 59: 647 – 651

    Article  CAS  Google Scholar 

  • Lotze MT, Grimm EA, Mazumder A, Strausser JL, Rosenberg SA (1981) Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor. Cancer Res 41: 4420 – 4425

    PubMed  CAS  Google Scholar 

  • Mazumder A, Rosenberg SA (1984) Successful immunotherapy of natural killer resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin-2. J Exp Med 159: 495 – 507

    Article  PubMed  CAS  Google Scholar 

  • Morales A, Nickel JC (1986) Immunotherapy of superficial bladder cancer with BCG. World J Urol 3: 209 – 214

    Article  Google Scholar 

  • Morgan DA, Ruscetti FW, Gallo RC (1976) Growth of thymus derived lymphocytes from human bone marrow. Science 193: 1007 – 1008

    Article  PubMed  CAS  Google Scholar 

  • Morita R, Yonese Y, Minato N (1987) In vivo distribution of recombinant interleukin-2-activated autologous lymphocytes administered by intra-arterial infusion in patients with renal cell carcinoma. JNCI 78: 441 – 447

    PubMed  CAS  Google Scholar 

  • Nakano E, Yasuharu T, Ichikaw Y et al. (1985) Cytotoxic activity of peripheral blood lymphocytes grown with interleukin-2 against autologous cultured tumour cells in patients with renal cell carcinoma: Preliminary report. J Urol 134: 24–28

    PubMed  CAS  Google Scholar 

  • Nauts HC (1969) The apparently beneficial effects of bacterial infections on host resistance to cancer: End results in 435 cases. N Y Cancer Res Inst Monogr 8: 1 – 57

    Google Scholar 

  • Nossal GJV (1987) The basic components of the immune system. N Engl J Med 316: 320 – 325

    Article  Google Scholar 

  • Rabinowich H, Cohen R, Bruderman T et al. (1987) Functional analysis of mononuclear cells infiltrating into tumors: Lysis of autologous human tumor cells by cultured lymphocytes. Cancer Res 47: 173–177

    PubMed  CAS  Google Scholar 

  • Reif AE (1986) Relationship of success in classical immunotherapy to the relative immunorejective strength of the tumor. JNCI 77: 899 – 908

    PubMed  CAS  Google Scholar 

  • Rosenberg SA, Lotze MT, Mool LM et al. (1985) Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer. New Engl J Med 313: 1485 – 1492

    Article  PubMed  CAS  Google Scholar 

  • Rosenberg SA, Spiess P, Lafrenier R (1986) A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233: 1318 – 1321

    Article  PubMed  CAS  Google Scholar 

  • Nakano E, Yasuharu T, Ichikaw Y et al. (1985) Cytotoxic activity of peripheral blood lymphocytes grown with interleukin-2 against autologous cultured tumour cells in patients with renal cell carcinoma: Preliminary report. J Urol 134: 24–28

    PubMed  CAS  Google Scholar 

  • Schlom J (1986) Basic principles and applications of monoclonal antibodies in the management of carcinomas. Cancer Res 46: 3225 – 3238

    PubMed  CAS  Google Scholar 

  • Schmitz-Drager BJ, Ebert T, Ackermann R (1986): Intravesical treatment of superficial bladder carcinoma with interferons. World J Urol 3: 218 – 223

    Article  Google Scholar 

  • Tallberg T, Tykka H (1986) Specific active immunotherapy in advanced renal cell carcinoma: A clinical long-term follow-up study. World J Urol 3: 234–244.

    Article  Google Scholar 

  • Villasor RB (1965) The clinical use of BCG vaccine in stimulating host resistance to cancer. J Philippine Med Assoc 41: 619 – 624

    CAS  Google Scholar 

  • Yabro JW (1987) Advance in interferon therapy. Semin Oncol 14 [suppl 2], 1 – 60

    Google Scholar 

Download references

Authors
  1. S. A. Brosman
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St James’s University Hospital, Beckett Street, LS9 7TF, Leeds, UK

    Philip H. Smith MB, FRCS (Consultant Urologist) (Consultant Urologist)

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Brosman, S.A. (1989). Immunotherapy. In: Smith, P.H. (eds) Combination Therapy in Urological Malignancy. Clinical Practice in Urology. Springer, London. https://doi.org/10.1007/978-1-4471-1655-4_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1655-4_3

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-1657-8

  • Online ISBN: 978-1-4471-1655-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation